with type 2 diabetes participated at 91sites in the U.S. (May 2002 to August2003). A common clinical protocol wasapproved for each site by an institutionalreview board and in accordance with theprinciples described in the Declaration ofHelsinki, including all amendmentsthrough the 1996 South Africa revision(20). All subjects provided written in-formed consent before participation. This was a balanced, randomized,